Dr. Blechacz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4502 Medical Dr
San Antonio, TX 78229Phone+1 210-358-4000Fax+1 803-933-3049
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2007 - 2011- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2007
Mayo ClinicPost-Doctoral Fellowship, 2002 - 2005
Ruprecht Karl University Faculty of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2011 - 2025
SC State Medical License 2018 - 2021
MN State Medical License 2007 - 2011- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 536 citationsCholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†Boris Blechacz, Gregory J. Gores
Hepatology. 2008-07-01 - 344 citationsAssociation between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysisMatthias Briel, Ignacio Ferreira-González, John J. You, Paul J. Karanicolas, Elie A. Akl
BMJ. 2009-02-16 - 164 citationsEndoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related ColitisYinghong Wang, Hamzah Abu-Sbeih, Emily Mao, Noman Ali, Wei Qiao
Inflammatory Bowel Diseases. 2018-07-12
Journal Articles
- Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational StudyFelipe Samaniego, Boris Blechacz, Ahmed Kaseb, Bruno P Granwehr, Aung Naing, Issam I Raad, Ethan Miller, Harrys A Torres, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
